FIBROBIOLOGICS INC (FBLG) Stock Overview
NASDAQ:FBLG - US31573L1052 - Common Stock
FBLG Key Statistics, Chart & Performance
The current stock price of FBLG is 0.5886 USD. In the past month the price decreased by -13.02%. In the past year, price decreased by -62.75%.
FBLG Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.89 | 372.00B | ||
| AMGN | AMGEN INC | 13.47 | 157.94B | ||
| GILD | GILEAD SCIENCES INC | 14.83 | 142.77B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.32 | 101.47B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.92 | 63.65B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 71.2 | 40.39B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.78 | 33.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.66B | ||
| INSM | INSMED INC | N/A | 25.02B | ||
| NTRA | NATERA INC | N/A | 22.61B | ||
| BIIB | BIOGEN INC | 8.7 | 20.41B |
Related stock screener links
About FBLG
Company Profile
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2024-01-31. The firm is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). The company is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. The company is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.
Company Info
FIBROBIOLOGICS INC
455 E. Medical Center Blvd, Suite 300
Houston TEXAS US
Employees: 10
Phone: 12816715150
FIBROBIOLOGICS INC / FBLG FAQ
What is the stock price of FIBROBIOLOGICS INC today?
The current stock price of FBLG is 0.5886 USD. The price decreased by -0.05% in the last trading session.
What is the ticker symbol for FIBROBIOLOGICS INC stock?
The exchange symbol of FIBROBIOLOGICS INC is FBLG and it is listed on the Nasdaq exchange.
On which exchange is FBLG stock listed?
FBLG stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FIBROBIOLOGICS INC stock?
9 analysts have analysed FBLG and the average price target is 10.88 USD. This implies a price increase of 1748.45% is expected in the next year compared to the current price of 0.5886. Check the FIBROBIOLOGICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FIBROBIOLOGICS INC worth?
FIBROBIOLOGICS INC (FBLG) has a market capitalization of 22.52M USD. This makes FBLG a Nano Cap stock.
How many employees does FIBROBIOLOGICS INC have?
FIBROBIOLOGICS INC (FBLG) currently has 10 employees.
What are the support and resistance levels for FIBROBIOLOGICS INC (FBLG) stock?
FIBROBIOLOGICS INC (FBLG) has a resistance level at 0.59. Check the full technical report for a detailed analysis of FBLG support and resistance levels.
Should I buy FIBROBIOLOGICS INC (FBLG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FBLG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FBLG, evaluating the profitability, health, valuation and growth aspects
- FIBROBIOLOGICS INC (FBLG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FIBROBIOLOGICS INC (FBLG) Sales and EPS estimates to see what analysts future expectations are.
- FIBROBIOLOGICS INC (FBLG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FIBROBIOLOGICS INC (FBLG) Insider and Institutional Ownership to learn about the owners and their transactions.
- FIBROBIOLOGICS INC (FBLG) Stock Chart to make your own analysis
- FIBROBIOLOGICS INC (FBLG) Latest news and press-releases to stay up to date.
Does FIBROBIOLOGICS INC (FBLG) stock pay dividends?
FBLG does not pay a dividend.
When does FIBROBIOLOGICS INC (FBLG) report earnings?
FIBROBIOLOGICS INC (FBLG) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of FIBROBIOLOGICS INC (FBLG)?
FIBROBIOLOGICS INC (FBLG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.36).
What is the Short Interest ratio of FIBROBIOLOGICS INC (FBLG) stock?
The outstanding short interest for FIBROBIOLOGICS INC (FBLG) is 3.46% of its float. Check the ownership tab for more information on the FBLG short interest.
FBLG Technical Analysis
FBLG Financial Highlights
Over the last trailing twelve months FBLG reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 61.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -95.08% | ||
| ROE | -1537.56% | ||
| Debt/Equity | 9.38 |
FBLG Forecast & Estimates
9 analysts have analysed FBLG and the average price target is 10.88 USD. This implies a price increase of 1748.45% is expected in the next year compared to the current price of 0.5886.